MANKIND PHARMA
|
The Current P/S Ratio of MANKIND PHARMA is 6.86.
| Share Price | ₹2,371.8 | Jun 10,2026 |
| Market Cap | ₹97,953.3 Cr | |
| Sales-TTM | ₹14,277.6 Cr | TTM-Consolidated Results |
| Price/Sales | 6.86x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹97,953.3 Cr] as on Jun 10,2026
(/) Sales [ ₹14,277.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.86x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay '6.86 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !
The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MANKIND PHARMA
PS Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.43x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.97x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| MANKIND PHARMA | 14,277.6 | 6.86 | 97,953.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.33 | 428,785.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.69 | 176,242.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.81 | 151,058.0 |
| CIPLA LTD | 28,162.6 | 3.95 | 111,180.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.15 | 106,149.0 |
| LUPIN LTD | 27,958.0 | 3.68 | 102,818.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.07 | 110,474.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.49 | 83,654.2 |
| LAURUS LABS LTD | 6,812.9 | 10.98 | 74,827.3 |
| BIOCON LTD | 16,927.0 | 3.96 | 67,113.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.49x |
| Max industry PS | 16.69x |
| Median industry PS | 4.07x |
| Average industry PS | 6.72x |
You may also like the below Video Courses